- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | AUSTRALIAN CLINICAL LABS LIMITED: Change in substantial holding from MUFG | - | ASX | ||
| Do | AUSTRALIAN CLINICAL LABS LIMITED: Change in substantial holding | - | ASX | ||
| AUSTRALIAN CLINICAL LABS Aktie jetzt für 0€ handeln | |||||
| Mo | AUSTRALIAN CLINICAL LABS LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 09.07. | AUSTRALIAN CLINICAL LABS LIMITED: Becoming a substantial holder | - | ASX | ||
| 02.07. | AUSTRALIAN CLINICAL LABS LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 02.07. | AUSTRALIAN CLINICAL LABS LIMITED: Initial Director's Interest Notice - Dr Amandeep Hansra | - | ASX | ||
| 29.06. | AUSTRALIAN CLINICAL LABS LIMITED: Notification regarding unquoted securities - ACL | - | ASX | ||
| 25.06. | AUSTRALIAN CLINICAL LABS LIMITED: Change in substantial holding from MUFG | - | ASX | ||
| 24.06. | AUSTRALIAN CLINICAL LABS LIMITED: Change in substantial holding | - | ASX | ||
| 18.06. | AUSTRALIAN CLINICAL LABS LIMITED: Appointment of non-executive director - Dr Amandeep Hansra | - | ASX | ||
| 17.06. | AUSTRALIAN CLINICAL LABS LIMITED: Update on third party cyber incident impacting SunDoctors | - | ASX | ||
| 12.06. | AUSTRALIAN CLINICAL LABS LIMITED: Notification of cessation of securities - ACL | - | ASX | ||
| 09.06. | AUSTRALIAN CLINICAL LABS LIMITED: Becoming a substantial holder | - | ASX | ||
| 28.05. | AUSTRALIAN CLINICAL LABS LIMITED: Appointment of new Group CEO | - | ASX | ||
| 27.05. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| 25.05. | AUSTRALIAN CLINICAL LABS LIMITED: Change in substantial holding from CBA | - | ASX | ||
| 25.05. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| 20.05. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| 20.05. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| 20.05. | AUSTRALIAN CLINICAL LABS LIMITED: Change in substantial holding | - | ASX |
1 2 3 4 5 Weiter >>
107 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 29,300 | -2,33 % | DEUTSCHE BANK RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Carl Zeiss Meditec von 30 auf 28 Euro gesenkt und die Einstufung auf "Hold" belassen. In einem am Dienstag vorliegenden Ausblick... ► Artikel lesen | |
| ECKERT & ZIEGLER | 13,950 | -1,34 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| MEDTRONIC | 72,78 | +0,11 % | Medtronic plc: Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain | Acquisition adds category-defining SPRINT® PNS technology to Medtronic's pain therapy portfolio-the broadest in the industry.¹
GALWAY, Ireland, July 16, 2026 /PRNewswire/... ► Artikel lesen | |
| STRATEC | 19,540 | -2,30 % | DEUTSCHE BANK RESEARCH stuft STRATEC BIOMEDICAL SYSTEMS AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Stratec mit einem Kursziel von 21 Euro auf "Hold" belassen. Jan Koch geht davon aus, dass sich das Geschäft des Spezialisten... ► Artikel lesen | |
| M1 KLINIKEN | 18,360 | 0,00 % | Dividendenbekanntmachungen (09.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCENTURE PLC IE00B4BNMY34 1,63 USD 1,4275 EUR ALIMENTATION COUCHE-TARD INC CA01626P1484 0,215 CAD 0,1328 EUR ANPARIO PLC GB00B3NWT178 0... ► Artikel lesen | |
| ZIMMER BIOMET | 81,30 | +2,03 % | Zimmer Biomet names new president of Asia Pacific | ||
| RYMAN HEALTHCARE | 1,055 | +2,43 % | Ryman Healthcare Reports Steady Q1 Trading Amidst Market Challenges | ||
| SONIC HEALTHCARE | 13,222 | -0,71 % | Dividendenbekanntmachungen (04.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ASPIAL LIFESTYLE LIMITED SG2E90982678 0,008 SGD 0,0053 EUR AUTOLIV INC US0528001094 0,87 USD 0,7491 EUR AVERY DENNISON CORP US0536111091 0... ► Artikel lesen | |
| AMBU | 9,210 | -0,59 % | Ambu A/S: Interim Report For Q1 2025/26 | 4.2.2026 07:04:05 CET | Ambu A/S |
Interim report (Q1 and Q3)
Ambu had a solid start to the 2025/26 financial year, reflected by continued strong growth momentum. Endoscopy Solutions grew by 14.4%... ► Artikel lesen | |
| TRANSMEDICS GROUP | 64,38 | -0,40 % | TransMedics Group, Inc.: TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH | Strategic investment in Germany-based PAD Aviation, a premier European private aviation operator, lays the foundation for TransMedics to establish a dedicated organ... ► Artikel lesen | |
| CLINICA BAVIERA | 57,40 | +0,35 % | Dividendenbekanntmachungen (10.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALIBABA GROUP HOLDING LTD KYG017191142 0,1312 USD 0,1137 EUR ALIBABA GROUP HOLDING LTD SDR SGXE32143393 0,0259 SGD 0,0175 EUR ALTAREA... ► Artikel lesen | |
| CVS | 15,000 | 0,00 % | Converium Capital Inc.: Converium Capital Sends Letter to CVS Group Board Highlighting Company's Undervaluation and Urging £100 Million Share Buyback | Follows Extensive Private Engagement That Has Not Produced Meaningful Action
Converium Capital Inc. ("Converium"), which manages funds that own shares of CVS Group plc (LSE: CVSG) ("CVS Group"... ► Artikel lesen | |
| EMBLA MEDICAL | 3,505 | -2,64 % | EMBLA MEDICAL HF: Initiating New Share Buyback Program | ||
| EUROEYES | - | - | EUROEYES (01846): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 17 JULY 2026 | ||
| LUMEXA IMAGING | 11,170 | +0,27 % | Wall Street Analysts Think Lumexa (LMRI) Could Surge 44.08%: Read This Before Placing a Bet |
Das Unternehmen AUSTRALIAN CLINICAL LABS LIMITED kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AUSTRALIAN CLINICAL LABS LIMITED finden Sie auf Wallstreet Online.